Discover investment opportunities in Under 1 Dollar Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Under 1 Dollar Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Under 1 Dollar Stocks using our Smart AI Filter.
5 stocks found for "Under 1 Dollar Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.08 | ±71.6% | -1.8 | 0.00% | |||
1.56 | ±83.0% | -16.0 | 0.00% | |||
0.76 | ±100.0% | -0.1 | 0.00% | |||
1.11 | ±100.0% | — | 0.00% | |||
1.24 | ±72.2% | -6.2 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Kaixin Auto Holdings (NASDAQ: KXIN) revealed that Beijing Camping Club Sports and Culture Communication Co Ltd (Camping Club) has agreed to order about 20,000 new energy vehicles over the next five years. The value of the order totals RMB6 billion ($938 million).
Read moreQ: What are the potential growth drivers for Zomedica Corp (ZOM) in the veterinary healthcare market?
A: Zomedica focuses on producing diagnostic equipment and technology for veterinarians. Growth may come from increased demand for pet healthcare services, industry innovation, and animal diagnostics. Monitoring how well ZOM integrates new technologies like Truforma and partnerships will be crucial for assessing its potential trajectory.
Q: How does FuelCell Energy (FCEL) fit into the renewable energy sector?
A: FCEL develops fuel cell technologies for clean energy generation. Positioned within the renewable energy sector, its growth opportunities might be influenced by renewed interest in sustainable power solutions and public policies promoting green energy. However, competitive pressure and technological advancements are crucial factors to consider.
Q: What should investors know about Sundial Growers (SNDL) in the cannabis industry?
A: SNDL, a Canadian cannabis producer, may benefit from shifts in cannabis regulations and growing consumer demand. Yet, investors should be cautious of sector volatility, regulatory hurdles, and market saturation. Examining SNDL's product differentiation and market strategy can provide further insights.
Q: What are the risks associated with investing in Ideanomics (IDEX)?
A: IDEX operates in the fintech and electric vehicle sectors. Key risks include market competition, execution of business model diversifications, and regulatory challenges. Though it can gain from trends in digital finance and EV adoption, these sectors' rapid evolution could affect stability.
Q: How does MICT Inc. plan to leverage its presence in the financial technology space?
A: MICT aims to utilize its platforms for insurance solutions and financial services in China and other markets. It may gain from increasing digitalization in finance. However, investors should study regulatory impacts and market entry barriers that could affect its business model.
Q: What makes Vyant Bio (VYNT) potentially appealing to biotech investors?
A: VYNT focuses on employing technology for drug discovery and development. Potential allure lies in its innovative approach in the biotech niche, driven by partnerships and technology integration. Risks include clinical trial outcomes and financial sustainability given pre-profit status.